logo

Judith Currier, MD

Judith Currier, MD

Infectious Disease Los Angeles, CA

Professor of Medicine, UCLA-David Geffen School of Medicine

Office Address

Office Map
  • 200 Medical Plaza
    #214,365,530,420,120
    Los Angeles, CA 90095
    Phone: (310) 557-2273

Summary

  • Dr. Judith Currier, MD is a board certified infectious disease specialist in Los Angeles, California. She is currently licensed to practice medicine in California and Georgia. She is affiliated with Ronald Reagan UCLA Medical Center and UCLA Medical Center Santa Monica.

Dr. Currier's Clinical Specialties & Interests

  • Infectious Disease: HIV/AIDS Medicine

Dr. Currier's Education & Medical Training

  • Beth Israel Deaconess Medical CenterBeth Israel Deaconess Medical CenterFellowship, Infectious Disease
  • Beth Israel Deaconess Medical CenterBeth Israel Deaconess Medical CenterResidency, Internal Medicine
  • Dartmouth MedGeisel School of Medicine at DartmouthMedical School

Dr. Currier's Certifications & Licensure

  • CA State Medical LicenseCA State Medical License1993 - 2014
  • GA State Medical LicenseGA State Medical LicenseActive through 2013
  • American Board of Internal MedicineAmerican Board of Internal MedicineInternal Medicine
  • American Board of Internal MedicineAmerican Board of Internal MedicineInfectious Disease

Dr. Currier's Awards, Honors, & Recognition

  • SuperDoctors.comSuper DoctorSuperDoctors.com

Dr. Currier's Clinical Trials

Dr. Currier's Publications & Presentations

PubMed | Citations by Web of Science®

Grant Support

  • Optimizing Antiretroviral Therapy In HIV
    Optimizing Antiretroviral Therapy In HIVNational Institute Of Allergy And Infectious Diseases
    2009 - 2012
  • Prospective Evaluation Of Antiviral Therapy And Cardiac Health
    Prospective Evaluation Of Antiviral Therapy And Cardiac HealthNational Heart, Lung, And Blood Institute
    2008 - 2011
  • Clinical Research Facilitation Core
    Clinical Research Facilitation CoreNational Institute Of Allergy And Infectious Diseases
    2008 - 2012
  • UCLA AIDS Prevention And Treatment Clinical Trials Unit
    UCLA AIDS Prevention And Treatment Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases
    2007 - 2012
  • A Pilot Study Of The Safety, Efficacy, And Tolerability Of Ezetimibe (Zetia?)
    A Pilot Study Of The Safety, Efficacy, And Tolerability Of Ezetimibe (Zetia?)National Center For Research Resources
    2007 - 2008
  • Sex Differences In Pharmacokinetics Of Lopinavir/Ritonavir Among HIV-1 Infect
    Sex Differences In Pharmacokinetics Of Lopinavir/Ritonavir Among HIV-1 InfectNational Center For Research Resources
    2007 - 2008
  • A Phase Ii/Iii, Randomized, Double-Blind, Placebo-Controlled Trial Of Uridine
    A Phase Ii/Iii, Randomized, Double-Blind, Placebo-Controlled Trial Of UridineNational Center For Research Resources
    2007 - 2009
  • A Phase IV, Prospective, Randomized, Open-Label Evaluation Of The Efficacy Of
    A Phase IV, Prospective, Randomized, Open-Label Evaluation Of The Efficacy OfNational Center For Research Resources
    2006 - 2010
  • Stavudine Drug Levels And The Risk Of Metabolic Toxicity In Patients Receivin
    Stavudine Drug Levels And The Risk Of Metabolic Toxicity In Patients ReceivinNational Center For Research Resources
    2006 - 2008
  • Phase II, Randomized, Double-Blind Study Of The Safety And Efficacy Of SCH 41
    Phase II, Randomized, Double-Blind Study Of The Safety And Efficacy Of SCH 41National Center For Research Resources
    2006 - 2010
  • Fat Redistribution And Metabolic Change In HIV Infection: Protocol 2 (Fram 2)
    Fat Redistribution And Metabolic Change In HIV Infection: Protocol 2 (Fram 2)National Center For Research Resources
    2006 - 2007
  • Stavudine Drugs &Risk Metabolic Toxicity: PATS Recv Antiretroviral Therapy:Aids
    Stavudine Drugs &Risk Metabolic Toxicity: PATS Recv Antiretroviral Therapy:AidsNational Center For Research Resources
    2005 - 2005
  • A Phase II, Randomized, Double-Blind, Placebo-Controlled Study Of Once-Weekly
    A Phase II, Randomized, Double-Blind, Placebo-Controlled Study Of Once-WeeklyNational Center For Research Resources
    2005 - 2005
  • A Randomized, Double-Blind, Placebo-Controlled Study Of Metformin And Rosigli
    A Randomized, Double-Blind, Placebo-Controlled Study Of Metformin And RosigliNational Center For Research Resources
    2005 - 2005
  • A Study Investigating Plasma Levels Of D-Chiro-Inositol In Patients With HIV
    A Study Investigating Plasma Levels Of D-Chiro-Inositol In Patients With HIVNational Center For Research Resources
    2005 - 2005
  • Adults AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (Allr
    Adults AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (AllrNational Center For Research Resources
    2005 - 2006
  • A Prospective Observational Study Of Virologic And Immunologic Changes In HIV
    A Prospective Observational Study Of Virologic And Immunologic Changes In HIVNational Center For Research Resources
    2005 - 2006
  • Adults AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (Allr...
    Adults AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (Allr...National Center For Research Resources
    2004 - 2004
  • Study Investigating Plasma Levels Of D-Chiro-Inositol
    Study Investigating Plasma Levels Of D-Chiro-InositolNational Center For Research Resources
    2004 - 2004
  • AIDS Clinical Trials Unit
    AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases
    2004 - 2006
  • Stavudine Drug Levels And The Risk Of Metabolic Toxicity In Patients Receivin...
    Stavudine Drug Levels And The Risk Of Metabolic Toxicity In Patients Receivin...National Center For Research Resources
    2004 - 2004
  • Phase II, Randomized, Double-Blind, Placebo-Controlled
    Phase II, Randomized, Double-Blind, Placebo-ControlledNational Center For Research Resources
    2004 - 2004
  • Randomized, Double-Blind, Placebo-Controlled Study Of
    Randomized, Double-Blind, Placebo-Controlled Study OfNational Center For Research Resources
    2004 - 2004
  • Pilot Study Of The Safety, Efficacy, And Tolerability
    Pilot Study Of The Safety, Efficacy, And TolerabilityNational Center For Research Resources
    2004 - 2004
  • Metabolic Complication Of HIV Infection
    Metabolic Complication Of HIV InfectionNational Institute Of Allergy And Infectious Diseases
    2003 - 2007
  • STD Faculty Expansion Program
    STD Faculty Expansion ProgramNational Center For Hiv, Viral Hepatitis, Stds And Tb Prevention
    2003 - 2006
  • Actg365--Steady State PK Interaction Study Of Indinavir &Rifabutin
    Actg365--Steady State PK Interaction Study Of Indinavir &RifabutinNational Center For Research Resources
    1999 - 2002
  • 24 Week Study Of Indinavir Sulfate 800 MG Q8h Versus 1200 MG Q12h
    24 Week Study Of Indinavir Sulfate 800 MG Q8h Versus 1200 MG Q12hNational Center For Research Resources
    1999 - 2002
  • Viracept (BID) And Sanquinavir (BID) Compared With Tid Dosing In HIV
    Viracept (BID) And Sanquinavir (BID) Compared With Tid Dosing In HIVNational Center For Research Resources
    1999 - 2002
  • Phase II, Randomized Trial Of Amprenavir As PART Of Dual Protease Inhibitor
    Phase II, Randomized Trial Of Amprenavir As PART Of Dual Protease InhibitorNational Center For Research Resources
    1999 - 2001
  • Phase I/II Trial Of Nandrolone Decanoate In Women W/ HIV Associated Weight Loss
    Phase I/II Trial Of Nandrolone Decanoate In Women W/ HIV Associated Weight LossNational Center For Research Resources
    1998 - 2002
  • Phase II, Randomized Study Of The Safety And Efficacy Of Viracept
    Phase II, Randomized Study Of The Safety And Efficacy Of ViraceptNational Center For Research Resources
    1998 - 1999

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • BCBS Blue Card PPO
  • BCBS California CaliforniaCare HMO
  • BCBS California PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • First Health PPO
  • Great West PPO
  • Health Net California Large Group PPO
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PHCS PPO - Kaiser
  • Multiplan PPO
  • Pacificare HMO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO

Alternate Names

  • Dr. Judith Currier, Dr. Judith Currier, MD, Dr. J Currier, Dr. Judith Silverstein Currier

32 Colleague Invites!
Is this you? If so, register to see 32 messages.

Physicians, view Dr. Currier's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV